![Keith Regnante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Regnante
Directeur Financier/CFO chez
KEROS THERAPEUTICS, INC.
Fortune : 110 036 $ au 31/05/2026
Profil
Keith C.
Regnante is currently Chief Financial Officer at Keros Therapeutics, Inc. since 2020.
Formerly, Mr. Regnante was Chief Financial & Accounting Officer at Wave Life Sciences Ltd. from 2016 to 2020, Vice President-Finance at Shire Pharmaceuticals, Inc. from 2014 to 2016, Head-Research & Development Finance at ARIAD Pharmaceuticals, Inc. from 2013 to 2014, and Senior Director-Corporate Finance at Biogen, Inc. from 2011 to 2013.
Education includes an undergraduate degree from Tufts University and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 9 781 ( 0,05% ) | 110 036 $ | 31/05/2026 |
Postes actifs de Keith Regnante
| Sociétés | Poste | Début |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Directeur Financier/CFO | 01/02/2020 |
Anciens postes connus de Keith Regnante
| Sociétés | Poste | Fin |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Directeur Financier/CFO | 09/01/2020 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/08/2016 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2014 |
| BIOGEN INC. | Public Communications Contact | 01/08/2013 |
Formation de Keith Regnante
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
